Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest treatment of multiple sclerosis Stories

2013-02-17 23:01:36

Ironclad Integrity Ltd. announces Dr. Gary M. Levin´s natural Multiple Sclerosis treatment as an alternative therapy that delivers effective results. Denver, CO (PRWEB) February 17, 2013 Health experts know very little about the causes of Multiple Sclerosis. Risk factors are still not accurately highlighted and medicine such as antidepressants, interferons, mioxantrone and steroids features side-effects that many MS patients don´t feel are worth in the long run. According to...

2013-01-16 08:24:44

EXTON, Penn., Jan. 16, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that the recent commercial availability of Genzyme's Aubagio, the second oral disease-modifying agent (DMA) to the market following Novartis's launch of Gilenya in late 2010, is top of mind for few neurologists as a change in the management or treatment of their multiple sclerosis (MS) patients. Instead, data from the...

2012-12-28 05:02:45

Part 1: Overview, progress toward stopping MS. New York, NY (PRWEB) December 27, 2012 MS research continued to advance on many fronts in 2012. This year saw:     The approval of a second oral therapy for relapsing forms of MS and other emerging treatments progressing through the development pipeline;     The launch of the International Progressive MS Collaborative, the largest effort to date to speed research to stop progressive forms of MS;...

New Treatment For Multiple Sclerosis Offers Promising Results
2012-11-01 09:25:28

Lawrence LeBlond for redOrbit.com - Your Universe Online A new drug to fight multiple sclerosis (MS) is showing promise as one of the “most effective” treatment options ever produced for the debilitating disease, according to UK researchers. The drug, which is used to ℠reboot´ a person´s immune system, has been shown to be effective in MS patients who have already failed to respond to the first drug with which they were treated, as well as those who have gone...

2012-07-18 06:37:58

(Ivanhoe Newswire)– A widely prescribed MS treatment may not be as effective in the long term as some would have hoped. New research shows that there´s no strong evidence that a group of drugs, beta interferons (ß-IFNs), prescribed to treat MS, had a measurable impact on the long-term disability progression of the disease. The study was led by researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of...

2012-07-18 01:28:25

Among patients with relapsing-remitting multiple sclerosis (MS), treatment with the widely-prescribed drug to treat MS, interferon beta, was not associated with less progression of disability, according to a study in the July 18 issue of JAMA. "A key feature of MS is clinical progression of the disease over time manifested by the accumulation of disability. Interferon beta drugs are the most widely prescribed disease-modifying drugs approved by the U.S. Food and Drug Administration for the...

2012-07-16 12:10:34

Research conducted by Jesus Lovera, MD, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has shown that stress management treatment significantly reduced the formation of new brain lesions in people with multiple sclerosis (MS) over the course of treatment. These lesions are markers of disease activity used to objectively measure disease status. The work is published ahead of print and is now available online in Neurology. "Our research found that...

2012-06-16 00:50:09

But there may be some benefit to those at the lower end of the disability scale The first large non-commercial study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS) shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale. The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study...

2012-05-23 02:26:59

TORONTO, May 23, 2012 /CNW/ - Today Biogen Idec announced that Health Canada has approved a product monograph change for TYSABRI® that will help enable individual benefit risk assessment for patients with multiple sclerosis (MS). The new label identifies anti-JC virus (JCV) antibody status as a risk factor for developing an uncommon, but serious, brain infection known as progressive multifocal leukoencephalopathy (PML). This marks the third risk factor identified to help...

2012-05-16 05:00:52

(Ivanhoe Newswire) — A new study finds that smoked cannabis can provide relief from pain and muscular tightness - otherwise known as spasticity — in people with multiple sclerosis at the risk of adverse cognitive effects. Spasticity causes patients with multiple sclerosis to suffer from muscular tightness that is difficult to control, often uncomfortable and disabling. Spasticity can be relieved by some drugs, but they can have adverse effects and often do not always improve...